MEDVF OTC
Medivolve Inc.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: -95.0%
1Y: -95.0%
3Y: -99.7%
5Y: +575.0%
$0.00
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$686K
-50.5% ▼
5Y CAGR: +108.0%
Gross Profit
$575K
-29.2% ▼
5Y CAGR: +100.8%
Operating Income
-$4M
+75.3% ▲
Net Income
-$16M
+10.4% ▲
EPS (Diluted)
$-0.61
+10.3% ▲
EBITDA
-$3M
+74.3% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|
| Revenue | -$152K | $11M | $87M | $1M | $686K |
| YoY Growth | -961.5% | +7062.5% | +720.4% | -98.4% | -50.5% |
| Cost of Revenue | $1M | $6M | $50M | $576K | $111K |
| Gross Profit | -$1M | $5M | $37M | $813K | $575K |
| Gross Margin | 788.2% | 43.5% | 42.1% | 58.6% | 83.8% |
| R&D Expenses | $0 | $0 | $0 | $0 | $380 |
| SG&A Expenses | $2M | $10M | $14M | $13M | $4M |
| Operating Expenses | -$152K | $29M | $37M | $15M | $4M |
| Operating Income | -$3M | -$24M | -$128K | -$14M | -$4M |
| Operating Margin | 1694.7% | -230.8% | -0.1% | -1044.1% | -521.5% |
| Interest Expense | $0 | $4M | $483K | $238K | $293K |
| Income Before Tax | -$3M | -$38M | -$154K | -$19M | -$4M |
| Tax Expense | $0 | $0 | $6M | -$5M | $0 |
| Net Income | -$3M | -$38M | -$7M | -$18M | -$16M |
| Net Margin | 1788.2% | -357.0% | -7.6% | -1323.1% | -2397.5% |
| EPS (Diluted) | $-1.19 | $-5.66 | $-0.34 | $-0.68 | $-0.61 |
| EBITDA | -$2M | -$30M | $19M | -$12M | -$3M |
| Shares Outstanding | 2M | 7M | 28M | 27M | 27M |